FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

560311000001102: Zomig 2.5mg tablets (AstraZeneca) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16735301000001119 Zomig 2.5mg tablets (AstraZeneca) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
112399701000001119 Zomig 2.5mg tablets (Grunenthal Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zomig 2.5mg tablets (AstraZeneca) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) Is a Product containing precisely zolmitriptan 2.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) Has excipient Lactose false Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) Has active ingredient Zolmitriptan false Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) Is a Zomig true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) Has specific active ingredient Zolmitriptan true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Is pack of False Zomig 2.5mg tablets (AstraZeneca) Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Is pack of False Zomig 2.5mg tablets (AstraZeneca) Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Has AMP True Zomig 2.5mg tablets (AstraZeneca) Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Has AMP True Zomig 2.5mg tablets (AstraZeneca) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start